Literature DB >> 20603486

The case against confirmatory tests for determining brain death in adults.

Eelco F M Wijdicks1.   

Abstract

The determination of brain death is based on a comprehensive clinical assessment. A confirmatory test-at least, in adult patients in the United States-is not mandatory, but it typically is used as a safeguard or added when findings on clinical examination are unwontedly incomplete. In other countries, confirmatory tests are mandatory; in many, they are optional. These tests can be divided into those that test the brain's electrical function and those that test cerebral blood flow. A false-positive result (i.e., the test result suggests brain death, but clinically the patient does not meet the criteria) is not common but has been described for tests frequently used to determine brain death. A false-negative result (i.e., the test result suggests intact brain function, but clinically the patient meets the criteria) in one test may result in more confirmatory tests and no resolution when the test results diverge. Also, pathologic studies have shown that considerable areas of viable brain tissue may remain in patients who meet the clinical criteria of brain death, a fact that makes these tests less diagnostic. Confirmatory tests are residua from earlier days of refining comatose states. A comprehensive clinical examination, when performed by skilled examiners, should have perfect diagnostic accuracy.

Entities:  

Mesh:

Year:  2010        PMID: 20603486     DOI: 10.1212/WNL.0b013e3181e62194

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Protracted cerebral circulatory arrest and cortical electrical silence coexisting with preserved respiratory drive and flexor motor response.

Authors:  K P Budohoski; M J H Aries; P J Kirkpatrick; A Lavinio
Journal:  Br J Anaesth       Date:  2012-08       Impact factor: 9.166

2.  Practice variability in brain death determination: a call to action.

Authors:  Claire N Shappell; Jeffrey I Frank; Khalil Husari; Matthew Sanchez; Fernando Goldenberg; Agnieszka Ardelt
Journal:  Neurology       Date:  2013-11-06       Impact factor: 9.910

3.  CT and MR perfusion can discriminate severe cerebral hypoperfusion from perfusion absence: evaluation of different commercial software packages by using digital phantoms.

Authors:  Ikuko Uwano; Kohsuke Kudo; Makoto Sasaki; Soren Christensen; Leif Østergaard; Kuniaki Ogasawara; Akira Ogawa
Journal:  Neuroradiology       Date:  2011-07-08       Impact factor: 2.804

4.  Brain death determination: still a lot to learn, still a lot to do….

Authors:  Panayiotis Varelas
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

5.  Renaissance of criticism on the concept of brain death--the role of legal medicine in the context of the interdisciplinary discussion.

Authors:  L Markert; B Bockholdt; M A Verhoff; S Heinze; M Parzeller
Journal:  Int J Legal Med       Date:  2015-07-15       Impact factor: 2.686

Review 6.  [Diagnosis of irreversible loss of brain function ("brain death")-what is new?]

Authors:  Uwe Walter; Stephan A Brandt
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

7.  Death determined by neurological criteria: the next steps.

Authors:  M Smith; G Citerio
Journal:  Intensive Care Med       Date:  2017-01-24       Impact factor: 17.440

8.  Truly Reconciling the Case of Jahi McMath.

Authors:  D Alan Shewmon
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

Review 9.  Computed tomography angiography in the diagnosis of brain death: a systematic review and meta-analysis.

Authors:  Andreas H Kramer; Derek J Roberts
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

10.  Computed tomographic angiography criteria in the diagnosis of brain death-comparison of sensitivity and interobserver reliability of different evaluation scales.

Authors:  Marcin Sawicki; R Bohatyrewicz; K Safranow; A Walecka; J Walecki; O Rowinski; J Solek-Pastuszka; Z Czajkowski; M Guzinski; M Burzynska; J Wojczal
Journal:  Neuroradiology       Date:  2014-05-07       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.